can you have surgery on semaglutide and Body Contouring | Dr. Shruti Tannan Bariatric surgery VS. Semaglutide -

The Food and Drug Administration (FDA) only approved Wegovy (semiglutide) as a chronic weight management drug for the obese and overweight in 2021, followed by Mounjaro and Zepbound (both tirzepatides) in 2022 and 2023

Make the skin look more radiant, clear, smooth, and even

By working with both incretin pathways your body already uses, tirzepatide may support deeper appetite regulation, larger and more sustained weight loss, and better glycemic stability than GLP-1 therapy alone

Unknown long-term profile: No human safety data, so caution and monitoring are advised

BMI over 27 with a weight-related condition: This includes individuals who have high blood pressure, type 2 diabetes, or high cholesterol

Muckenthaler MU, Rivella S, Hentze MW, Galy B